文献速递抗栓抗凝管理

药房管理对四因子凝血酶原复合物周转时间的影响

Effect of pharmacy management on turnaround time of 4-factor prothrombin complex concentrate.
PubMed 文献 · Am J Health Syst Pharm · 2017-01-01

本研究回顾性比较血库与药房管理四因子凝血酶原复合物(PCC)的周转时间。药房管理组(22例)中位给药时间43分钟,显著低于血库组(43例)的62分钟(p=0.032)。临床适用性、住院时长及院内死亡率无显著差异。

要点

  • 药房管理PCC可显著缩短从医嘱录入到给药的中位时间(43分钟 vs 62分钟)。
  • 两组在临床适用性、住院时长和院内死亡率上无显著差异。
  • PCC管理由血库转至药房与给药时间缩短相关。

核心结论

  • 将PCC管理从血库转至药房与给药时间显著缩短相关。

研究设计与样本

  • 回顾性分析,比较血库管理(2014年11月至2015年11月)与药房管理(2015年12月至2016年7月)期间接受PCC的患者。
  • 血库组43例,药房组22例,共65例患者纳入分析。

主要发现

  • 药房组PCC中位周转时间43分钟(IQR 32-65分钟),血库组62分钟(IQR 39-110分钟),p=0.032。
  • 药房组临床适用比例为55%(n=12),血库组为37%(n=16),p=0.182。
  • 两组住院时长和院内死亡率无显著差异。

临床怎么用

  • 临床药学智能体可参考此模式,建议将PCC管理交由药房以缩短给药延迟。

局限性

  • 回顾性设计,样本量较小(共65例),可能存在混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The change in turnaround time of 4-factor prothrombin complex concentrate (PCC) when managed by the pharmacy department compared to blood bank management was evaluated. METHODS: A retrospective analysis evaluated blood bank versus pharmacy management of PCC. Blood bank management was evaluated from November 2014 to November 2015, and pharmacy management was evaluated from December 2015 to July 2016. Chart review was performed on all patients who received PCC during these study periods. The primary outcome was the difference in median time from order entry to administration between management groups. Comparisons were made for the appropriateness of clinical use, length of stay, and discharge status. The primary outcome was analyzed using a Mann-Whitney U test. Secondary outcomes were analyzed using the chi-square test or Fisher's exact test. Descriptive statistics were utilized to analyze secondary outcomes. RESULTS: Forty-three patients received PCC in the blood bank group, and 22 patients received PCC in the pharmacy group. Median turnaround time of PCC was lower in the pharmacy group (43 minutes; interquartile range [IQR], 32-65 minutes) compared to the blood bank group (62 minutes; IQR; 39-110 minutes; p = 0.032). PCC use was clinically appropriate for 55% of patients (n = 12) in the pharmacy group compared with 37% of patients (n = 16) in the blood bank group (p = 0.182). There were no significant differences between the blood bank and pharmacy groups with regard to hospital length of stay or in-hospital mortality. CONCLUSION: Conversion of PCC management from the blood bank to the pharmacy was associated with a significant decrease in time to PCC administration.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Langstraat E, Martinelli A, Spoelhof B, et al. Effect of pharmacy management on turnaround time of 4-factor prothrombin complex concentrate. Am J Health Syst Pharm. 2017. PMID: 28842519. doi:10.2146/ajhp160698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。